Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Summary

This protocol is designed to standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden in subjects participating in other studies (companion protocol) such as longitudinal studies of aging and studies of biomarkers for neurodegenerative diseases.

Timeline

Start

2009-12

Primary completion

2017-05-03

Completion

2017-05-03

Drugs

Indications